Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Department of Medicine
  4. Department of Metabolism, Digestion and Reproduction
  5. The impact of semicarbazide sensitive amine oxidase activity on rat aortic vascular smooth muscle cells
 
  • Details
The impact of semicarbazide sensitive amine oxidase activity on rat aortic vascular smooth muscle cells
File(s)
ijms-24-04946-v3.pdf (5.97 MB)
Published version
Author(s)
Manasieva, Vesna
Thakur, Shori
Lione, Lisa
Baydoun, Anwar
Skamarauskas, John
Type
Journal Article
Abstract
Semicarbazide-sensitive amine oxidase (SSAO) is both a soluble- and membrane-bound transmembrane protein expressed in the vascular endothelial and in smooth muscle cells. In vascular endothelial cells, SSAO contributes to the development of atherosclerosis by mediating a leukocyte adhesion cascade; however, its contributory role in the development of atherosclerosis in VSMCs has not yet been fully explored. This study investigates SSAO enzymatic activity in VSMCs using methylamine and aminoacetone as model substrates. The study also addresses the mechanism by which SSAO catalytic activity causes vascular damage, and further evaluates the contribution of SSAO in oxidative stress formation in the vascular wall. SSAO demonstrated higher affinity for aminoacetone when compared to methylamine (Km = 12.08 µM vs. 65.35 µM). Aminoacetone- and methylamine-induced VSMCs death at concentrations of 50 & 1000 µM, and their cytotoxic effect, was reversed with 100 µM of the irreversible SSAO inhibitor MDL72527, which completely abolished cell death. Cytotoxic effects were also observed after 24 h of exposure to formaldehyde, methylglyoxal and H2O2. Enhanced cytotoxicity was detected after the simultaneous addition of formaldehyde and H2O2, as well as methylglyoxal and H2O2. The highest ROS production was observed in aminoacetone- and benzylamine-treated cells. MDL72527 abolished ROS in benzylamine-, methylamine- and aminoacetone-treated cells (**** p < 0.0001), while βAPN demonstrated inhibitory potential only in benzylamine-treated cells (* p < 0.05). Treatment with benzylamine, methylamine and aminoacetone reduced the total GSH levels (**** p < 0.0001); the addition of MDL72527 and βAPN failed to reverse this effect. Overall, a cytotoxic consequence of SSAO catalytic activity was observed in cultured VSMCs where SSAO was identified as a key mediator in ROS formation. These findings could potentially associate SSAO activity with the early developing stages of atherosclerosis through oxidative stress formation and vascular damage.
Date Issued
2023-03-03
Date Acceptance
2023-03-02
Citation
International Journal of Molecular Sciences, 2023, 24 (5), pp.1-19
URI
http://hdl.handle.net/10044/1/103391
URL
https://www.mdpi.com/1422-0067/24/5/4946
DOI
https://www.dx.doi.org/10.3390/ijms24054946
ISSN
1422-0067
Publisher
MDPI AG
Start Page
1
End Page
19
Journal / Book Title
International Journal of Molecular Sciences
Volume
24
Issue
5
Copyright Statement
© 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
License URL
http://creativecommons.org/licenses/by/4.0/
Identifier
https://www.mdpi.com/1422-0067/24/5/4946
Publication Status
Published
Article Number
4946
Date Publish Online
2023-03-03
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback